Dobutamine administration: a proposal for a standardized approach.

Area of Science:

• Critical Care Medicine
• Cardiology
• Pharmacology

Background:

• Dobutamine is a common inotropic agent for critically ill patients with impaired cardiac contractility.
• Its benefit-risk profile is debated, and structured guidance for its use is lacking.

Purpose of the Study:

• To propose a pragmatic framework for dobutamine administration in clinical and experimental settings.
• To ensure rational and consistent use of dobutamine in shock with low cardiac output, including cardiogenic shock, septic shock, and low cardiac output syndrome (LCOS).

Main Methods:

• Dobutamine should be prescribed for acute circulatory failure with hypoperfusion and impaired cardiac contractility; low cardiac index alone is insufficient.
• Echocardiography is crucial for initial assessment, supplemented by continuous cardiac output monitoring for dose-response evaluation.
• A standardized approach involves a starting dose of 2.5 μg/kg/min with stepwise titration based on cardiac index and perfusion markers every 20 minutes.

Main Results:

• Escalation of dobutamine dose should be guided by significant cardiac index increase and resolution of hypoperfusion.
• Persistent hypoperfusion despite improved cardiac index suggests inadequate response, warranting cautious dose increases.
• Continued hypoperfusion with further cardiac index rise indicates a flow-independent deficit, discouraging further titration.

Conclusions:

• Dobutamine use requires clear indications and a standardized approach integrating continuous hemodynamic and perfusion monitoring.
• This strategy aims to optimize therapeutic benefits while minimizing unnecessary exposure and adverse effects.
• The proposed framework promotes rational and reproducible inotropic therapy in critical care settings.